Etretinate: A novel agent for the treatment of refractory sclerodermatous chronic graft versus host disease.

被引：0
|
作者：
Marcellus, DC [1 ]
Altomonte, V [1 ]
Farmer, ER [1 ]
Horn, TD [1 ]
Freemer, C [1 ]
Grant, J [1 ]
Vogelsang, GB [1 ]
机构：
[1] JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1579 / 1579
页数：1
相关论文
共 50 条
  • [41] Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease
    Bisaccia, Emil
    Palangio, Mark
    Gonzalez, Joselyn
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 45 (02) : 187 - 190
  • [42] Pentostatin in steroid refractory acute graft versus host disease.
    Jacobsohn, D
    Margolis, J
    Anders, V
    Phelps, M
    Grever, M
    Vogelsang, G
    BLOOD, 2002, 100 (11) : 420A - 420A
  • [43] EFFICACY AND SAFETY OF RUXOLITINIB IN THE TREATMENT OF CHRONIC REFRACTORY GRAFT VERSUS HOST DISEASE. EXPERIENCE IN 48 CONSECUTIVE PATIENTS
    Velao Sara, Redondo
    Sanfeliu Albert, Esquirol
    Canales Silvana, Novelli
    Ana Carolina, Caballero Gonzalez
    Diaz Ana, Garrido
    Pardo Jordi, Lopez
    Atanasio Carol, Moreno
    Silvanna Daniela, Saavedra Gerosa
    Gorrochategui Miquel, Granell
    Meijide Javier, Briones
    Gil Jordi, Sierra
    Irene, Garcia-Cadenas
    Bofarull Rodrigo, Martino
    HAEMATOLOGICA, 2021, 106 (10) : 276 - 277
  • [44] Sclerodermatous graft versus host disease treated with acetretin
    Jarrett, P.
    Chan, W. C.
    Raj, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2009, 50 (04) : A60 - A60
  • [45] Positive effect of an anabolic agent, oxandrolone, in chronic graft-versus-host disease.
    Roberts, SR
    Waide, S
    Pineiro, L
    Agura, E
    Vance, EA
    BLOOD, 2002, 100 (11) : 451B - 451B
  • [46] GLAT (Copaxone) for treatment of steroid-refractory acute graft versus host disease.
    Johnston, LJ
    Shizuru, JS
    Stockerl-Goldstein, KE
    Stuart, MJ
    Gasparetto, C
    Long, GD
    Rizzieri, DA
    Vredenburgh, JJ
    Blume, KG
    Negrin, RS
    Chao, NJ
    BLOOD, 2002, 100 (11) : 421A - 421A
  • [47] Efficacy of Mycophenolate Mofetil (MMF) in the treatment of chronic graft versus host disease.
    Lopez, F
    Parker, P
    Rodriguez, R
    Snyder, D
    Bhatia, R
    Cohen, S
    Fung, H
    Kashyap, A
    Krishnan, A
    Molina, A
    Nademanee, A
    O'Donnell, M
    Popplewell, L
    Rosenthal, J
    Sahebi, F
    Somlo, G
    Spielberger, R
    Stein, A
    Sweetman, R
    Forman, S
    BLOOD, 2001, 98 (11) : 398A - 398A
  • [48] Baricitinib Treatment for Chronic Refractory Graft Versus Host Disease: A Case Report
    Alchidiac, Jessy
    Bouaziz, Jean-David
    Michonneau, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S521 - S521
  • [49] Improving treatment of refractory chronic extensive graft-versus-host disease
    Elez, M.
    Stamatovic, D.
    Tukic, L.
    Tarabar, O.
    Balint, B.
    Skuletic, V.
    Tasic, O.
    Simic, L.
    Malesevic, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S413 - S414
  • [50] Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease
    Moreno-Romero, Juan A.
    Fernandez-Aviles, Francesc
    Carreras, Enric
    Rovira, Montserrat
    Martinez, Carmen
    Mascaro, Jose M., Jr.
    ARCHIVES OF DERMATOLOGY, 2008, 144 (09) : 1106 - 1109
12345